- This event has passed.
Understanding and treating gut microbiome dysfunction in Parkinson’s disease: The COMBO PD Clinical Trial
November 18, 2020 @ 2:00 pm - 3:00 pm
This Webinar will discuss emerging evidence on how changes in the gut microbiome could play a role in Parkinson’s disease onset and progression. It will also cover restoration of the gut microbiome as a potential strategy for diagnosis and treatment of Parkinson’s. Finally, the talk will outline how this approach of microbiome restoration for Parkinson’s will be evaluated in the COMBO-PD clinical trial led by Associate Professor John O’Sullivan and other neurologists. This study is currently enrolling participants at multiple trial sites in in South East Queensland.
Dr Richard Gordon is a Group Leader in Clinical Neuroscience at the UQ Centre for Clinical Research and an Advance Queensland Mid-Career Fellow. He leads a Translational Neuroscience research program which aims to discover and progress new treatments, repurposed drugs and biomarkers for Parkinson’s disease. His research has contributed to several important advances in our understanding of how inflammation and ‘inflammasomes’ can contribute to the Parkinson’s disease pathology and progression. Dr Gordon’s research program has been funded by the Michael J Fox Foundation, The Cure Parkinson’s Trust (UK), Shake It Up Australia Foundation, Wesley Medical Research and the Queensland Government. Dr Gordon is the research lead for the Queensland Drug Repurposing Initiative (QDRI), which aims to build research and clinical trials capacity to repurpose approved drugs as new treatments for neurodegenerative diseases such as Parkinson’s. He is also a Science Ambassador for the World Parkinson Coalition (WPC) and is involved in outreach and promotion of the 6th World Parkinson’s Congress to be held in June 2022.